Emily Ferris and Alex Arbuckle describe how using mint Lesion™ has enhanced their clinical trial operations, enabling “a more cooperative approach between [their] radiologists and oncologists” while simultaneously saving time and reducing costs.
Faced with a multitude of clinical trial site reads each day, Ms. Ferris and Mr. Arbuckle explain how they benefit from a more efficient workflow by using a dedicated software platform which provides a comprehensive and compliant response assessment and supports them in maintaining oversight of clinical trial imaging analysis design.
Ms. Ferris is a Lead Image Analyst and Mr. Arbuckle is a Clinical Research Imaging Core Manager at the University of Wisconsin Carbone Cancer Center.
Enhancing flexibility and communication while saving costs and time in clinical trials
Related Resources
Related Resources
New iRECIST Oncologic Response Criteria already in clinical use at the University Medical Center – Tübingen, Germany
Shortly following the release of the new iRECIST- oncologic response criteria (Lancet Oncology, March 2017) the University Medical Center in Tübingen,…
Mrs. Kelie Luby joins Mint Medical's team
Mrs. Kelie Luby will join Mint Medical’s team from January 2017 as new Vice President Clinical Trials Software and will be introduced at the upcoming…
Novel oncologic therapy response criteria (iRECIST and more)
Advances in oncology therapies, such as novel immune-related agents, require adapted and refined criteria and guidelines for the assessment and…